This conference is closed.

DEA Tableting and Encapsulating Machines Discussion
July 23, or 24, 2024
Arlington, VA (DEA Headquarters)

The Drug Enforcement Administration Diversion Control Division is hosting discussion sessions for entities that handle regulated machines (tableting and encapsulating machines). These sessions will facilitate an exchange of information between DEA, manufacturers, distributors, importers and exporters of regulated machines. These meetings will offer information about regulatory procedures including reporting and record keeping requirements, and are to solicit feedback from industry regarding current challenges and proposed regulatory and legislative solutions to address those challenges. You are invited to attend one of these discussions either in-person at DEA Headquarters in Arlington, Virginia, or virtually. Up to three representatives from each invited company may attend, but each person needs to register separately. Please note that sessions will be held at the following dates and times.

Tuesday July 23, and Wednesday July 24, 2024

If attending in person, please report to security to check-in up to 1/2 hour before meeting time.
Guests will be escorted to 7th floor training room after they go through security.

DEA Tableting and Encapsulating Machines Discussion
DEA Headquarters
700 Army Navy Dr., Arlington, VA 22212

There is no registration fee for this conference.

NOTE: Conference attendees may choose to attend in-person OR virtually, but will not be able to register for both.

Maximum Capacity (in-person) = 10 attendees each session.

If you do not have a DEA #, please use Guest ID "DEAGUESTHQ"

This conference is closed.

Any questions regarding this conference may be directed to: ODLL@dea.gov